Olive oil and CHD
This article was originally published in The Tan Sheet
Executive Summary
Qualified health claim linking monounsaturated fat from olive oil to lowered risk of coronary heart disease approved by FDA Nov. 1. Claim states "Limited and not conclusive scientific evidence suggests that eating about 2 tablespoons (23 g) of olive oil daily may reduce the risk of coronary heart disease due to the monounsaturated fat in olive oil. To achieve this possible benefit, olive oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product [name of food] contains [x] grams of olive oil." The qualified claim is the third FDA has cleared since the process for establishing such claims took effect last year (1"The Tan Sheet" July 14, 2003, p. 3)...
You may also be interested in...
Qualified Health Claims Scientific Evidence To Be Assessed, Ranked By FDA
FDA will rank qualified health claims for use on dietary supplement and food products based on an evaluation of the scientific evidence that supports them, according to guidelines announced July 10
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.